Wealthfront Advisers’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Buy |
202,283
+7,507
| +4% | +$270K | 0.02% | 288 |
|
|
2025
Q1 | $6.06M | Buy |
194,776
+5,841
| +3% | +$182K | 0.02% | 310 |
|
|
2024
Q4 | $4.82M | Buy |
188,935
+178,173
| +1,656% | +$4.55M | 0.01% | 338 |
|
|
2024
Q3 | $304K | Buy |
+10,762
| New | +$304K | ﹤0.01% | 832 |
|
|
2024
Q2 | – | Sell |
-33,821
| Closed | -$1.03M | – | 892 |
|
|
2024
Q1 | $1.03M | Sell |
33,821
-33,185
| -50% | -$1.01M | ﹤0.01% | 610 |
|
|
2023
Q4 | $1.88M | Sell |
67,006
-8,831
| -12% | -$248K | 0.01% | 476 |
|
|
2023
Q3 | $2.06M | Buy |
75,837
+30,489
| +67% | +$827K | 0.01% | 417 |
|
|
2023
Q2 | $1.39M | Sell |
45,348
-7,363
| -14% | -$226K | 0.01% | 492 |
|
|
2023
Q1 | $1.9M | Buy |
52,711
+10,082
| +24% | +$363K | 0.01% | 422 |
|
|
2022
Q4 | $1.68M | Buy |
42,629
+32,875
| +337% | +$1.3M | 0.01% | 440 |
|
|
2022
Q3 | $392K | Buy |
9,754
+2,580
| +36% | +$104K | ﹤0.01% | 651 |
|
|
2022
Q2 | $302K | Buy |
+7,174
| New | +$302K | ﹤0.01% | 684 |
|